Similarly, Liu et al. designed a nanoemulsion system for the co-delivery of TGF–β inhibitor and selenocysteine (SeC) to enhance NK cell tumor-killing efficacy against triple-negative breast cancer cells. The gene discussed is TGFB1; the disease is neoplasm.